Results 181 to 190 of about 382,033 (356)

Does Basal Cell Carcinoma Arise from a Precursor Lesion? [PDF]

J Invest Dermatol
Wong SY, Harms PW, Dlugosz AA.
europepmc   +1 more source

Lung metastasis of basal cell carcinoma on anterior chest wall: A rare case report [PDF]

, 2020
Widiastuti Soewondo, Viska W. Arianti, Yusuf Syaeful Nawawi, Muchtar Hanafi, Rita Budianti, Brian Wasita   +5 more
openalex   +1 more source

Differentiation Treatment Applied to Lung Cancer Model Reduces Pathogenic Traits in Vitro

Advanced Biology, EarlyView.
Non‐small cell lung cancer cells (A549) treated with a differentiation medium showed strong reduction in proliferation, migration, clonogenicity, spheroid formation and stemness markers, with enhanced adhesion properties and alveolar features, all pointing to a notably less aggressive phenotype in support of differentiation therapy as a promising ...
Alice Grossi, Paola Fulghieri, Abdurakhmon Aduvaliev, Karen Soffiantini, Irene Oldrati, Margherita Cavallo, Marco Biggiogera, Giorgia Pellavio, Umberto Laforenza, Monica Savio, Virginie Sottile   +10 more
wiley   +1 more source

Streamlined Management of Basal Cell Carcinoma with Dermoscopy: A Retrospective Case-Control Study. [PDF]

J Clin Med
Donoso F, Aguero R, Caussade MC, Peirano D, Hidalgo L, Villagrán S, De Amesti P, Meza V, Hasenberg J, Droppelmann K, Abarzúa-Araya Á, Camilo Castro-Ayala J, Paoli J, Uribe P, Navarrete-Dechent C.   +14 more
europepmc   +1 more source

Basal cell carcinoma of the scalp with spinal metastasis [PDF]

, 1998
Dicky Lam, Raj Ragoowansi, B.W.E.M. Powell   +2 more
openalex   +1 more source

Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy

Advanced Functional Materials, EarlyView.
Porous silicon nanoparticles (PSiNPs) reprogram macrophage endocytosis of manganese@albumin‐based TLR4 nanoagonists, driving TRIF‐biased TLR4 signaling, eliciting robust proinflammatory responses, and potentiating macrophage‐mediated immunotherapeutic effects against NSCLC.
Xiaomei Zhang, Huiying Li, Shuodan Huang, Linxuan Zhang, Yan Gao, Ruoran Wang, Xiaoyu Wang, Hélder A. Santos, Zhenyu Yin, Bing Xia   +9 more
wiley   +1 more source

Management of Giant Basal Cell Carcinoma with Atypical Location. [PDF]

J Clin Pract Res
Bozkurt F, Özyazgan İ, Naghizade B, Canöz Ö, Demiray S.   +4 more
europepmc   +1 more source

Vismodegib and orbital excision for treating locally advanced basal cell carcinoma

, 2018
Daniel T. Hogarty, Nicholas Dewhurst, Benjamin Burt   +2 more
openalex   +2 more sources

A Single‐Metal‐Doped Nanoplatform for Ferroptosis‐Driven cGAS‐STING Pathway Activation in Hepatocellular Carcinoma Immunotherapy

Advanced Functional Materials, EarlyView.
The cGAS‐STING pathway boosts HCC antitumor immunity but lacks specific activation. Nanoplatform ZMRPF induces HCC ferroptosis via lipid ROS, releasing mtDNA. It synergizes with ZMRPF‐released Mn2⁺ to activate cGAS‐STING, amplifies antigen‐presenting cell activity, reverses HCC immunosuppression, and enables robust systemic antitumor immunity ...
Yuchen Zhang, Shuang Feng, Jie Luo, Kaige Xu, Junfeng Guo, Xingyue Zhang, Mengxue Yuan, Qiang Luo, Yu Huang, Chaoqiang Fan, Kibret Mequanint, Donghui Zhu, Malcolm Xing, Shiming Yang   +13 more
wiley   +1 more source

Appearance of basal cell carcinoma on untreated capillary malformation. [PDF]

An Bras Dermatol
Buchroithner C, Lobos N, Neely G, Madrid A, Darlic V, Castro A.   +5 more
europepmc   +1 more source